|
As the U.S. Senate returns from its August recess, I
am preparing for what will surely be a busy fall
session and I will be focusing on major issues of
concern to Mainers and all Americans. Of the many
pressing issues, I believe that the Senate passage
of prescription drug importation legislation and
comprehensive reform of our nation’s intelligence
community are critical for the nation and must be
completed before the 108th Congress
adjourns.
Closer to home, I will continue to work with my
colleagues in the appropriations process to ensure
that vital funding for initiatives in Maine are
included in the final bills sent to the President.
Unquestionably, it is going to be a condensed
legislative calendar - dictated by the Presidential
Election on November 2 - and, thus, will require
consensus-building and a bipartisan approach to key
issues in order to pass these bills into law and
achieve real advancements for Maine, and the
country, at large.
America’s health care system is plagued by
escalating costs, particularly with respect to
prescription drugs. As we have all heard in news
accounts, Mainers and countless other Americans are
organizing trips to the Canadian border to purchase
cheaper medications in Canadian pharmacies. Joining
with Senator Byron Dorgan (D-ND), we introduced the
bipartisan "The Pharmaceutical Market Access and
Drug Safety Act" to allow the safe, regulated
importation of prescription drugs from Canada within
90 days of enactment, and from additional
industrialized nations in Europe and Australia one
year later.
With 28 cosponsors including Senators Ted Kennedy
(D-MA) and John McCain (R-AZ), our bipartisan
legislation is currently under consideration in the
Senate Committee on Health, Education, Labor and
Pensions - but it is poised to move this session,
and I am working closely with Senator Dorgan and our
colleagues in securing consideration - and passage -
of drug importation legislation by the full Senate
this fall. Americans should no longer have to cross
international borders to purchase affordable
prescription drugs that often originate in the
United States.
Also this fall, the Senate will rightly continue
its work to institute necessary reforms to the
Intelligence Community. In June, the Senate Select
Committee on Intelligence, of which I am a member,
issued a comprehensive report detailing the
institutional and systemic failures of the currently
fractured IC. Joining with Senator Dianne Feinstein
(D-CA), we have introduced legislation that will
establish a Director of National Intelligence (DNI)
who will have real budgetary and personnel authority
over the 15 intelligence agencies that comprise our
nation’s IC. By empowering a DNI with substantive
authority, we can strengthen our nation’s
intelligence structure, in part, by reducing the
turf war for resources currently plaguing the IC,
particularly with the Department of Defense which
controls more than 80 percent of the IC budget. In
July, the 9-11 Commission issued 41 recommendations
to reform intelligence capabilities and
accountability which included creating a DNI.
Additionally, I authored legislation that would
create an Inspector General for Intelligence, thus
improving the level of accountability the President,
the Congress and the American people can have over
our nation’s intelligence agencies and estimates.
Having conducted numerous hearings throughout the
August recess, the Senate is already making progress
in writing legislation that will modernize the IC,
promoting the "three C’s": coordination,
communication and cooperation. With bipartisan
consensus, we will work diligently to meet the
deadline of October 1st established by
the President for enacting meaningful reforms.
And, as mandated each year, the Senate will
continue working to pass the twelve remaining
appropriation bills for Fiscal Year 2005, which
include funding for homeland security, veterans and
housing, energy and water projects, foreign
operations, environmental projects, health and human
services, education, transportation, and
agriculture. As I have for 25 years in Congress, I
will be working closely with the rest of the
delegation this year to funding for critical
projects in Maine. These are just some of the major
issues my attention will be turned to when the
Senate returns. As the saying goes, the
unpredictability of the Senate is the only thing
that is predictable -- so I will continue to take an
active role in legislation that is vital to Maine
and her citizens so we can be sure that it rightly
reflects our views and priorities.
### |